Every orthopedic entrepreneur dreams of the endless upward slope.
You build a strong first product, clear regulatory hurdles, win champion surgeons, and launch hard. Sales climb. The revenue graph looks like the south face of Everest, and the pitch deck promises uninterrupted growth.
Then the curve flattens.
Revenue stalls at $5M, $10M, or $15M. Reps hit doors that stay closed. VACs stop treating you as a category creator and start viewing you as a single-feature line item. More marketing spend, harder sales pressure, and refined messaging change nothing.
You have hit your local maximum.
The Climber’s Dilemma
This is the same problem faced by a mountaineer determined to reach the highest summit in a vast range. Focused on the path ahead, the climber grinds upward until standing on what feels like the top. Only when the fog lifts does the painful truth appear: the peak is merely a foothill. Taller summits—the global maximum—rise in the distance.
You cannot leap from one summit to the next. The only way forward is to climb back down into the valley, cross difficult terrain, and start the ascent again.
In orthopedics, Product #1 is that first peak. It validates the technology, genera...
